Cutaneous melanoma

被引：0

作者：

de la Fuente-Garcia, Alberto ^{[1
]}

Ocampo-Candiani, Jorge ^{[1
]}

机构：

[1] Univ Autonoma Nuevo Leon, Serv Dermatol, Hosp Univ Jose E Gonzalez, Monterrey 64460, Nuevo Leon, Mexico

来源：

GACETA MEDICA DE MEXICO | 2010年 / 146卷 / 02期

关键词：

Cutaneous melanoma; sentinel node; LYMPH-NODE METASTASES; FOLLOW-UP TESTS; MALIGNANT-MELANOMA; MANAGEMENT; INTERLEUKIN-2; THERAPY; BIOPSY; DACARBAZINE; TOMOGRAPHY; EXPERIENCE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cutaneous melanoma is the most malignant skin tumor with great potential to develop metastases. For 50 years, its incidence has greatly increased worldwide, including Mexico. Although sonic risk factors are known, early diagnosis and treatment are still the only strategies that have shown to improve prognosis. Management of cutaneous melanoma is still a challenge. In this article we present a review and update of cutaneous melanoma, its epidemiology, etiology, risk factors, classification, diagnosis criteria, relevance of the sentinel node, management, treatment, and prevention.

引用

页码：126 / 135

页数：10

共 56 条

[1] The surgical management of metastatic melanoma [J].

Allen, PJ ;

Coit, DG .

ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (08) :762-770

[2]

Alonso O, 2003, EUR J DERMATOL, V13, P449

[3]

[Anonymous], CLIN PRACTICE GUIDEL

[4] Sunscreens - what's important to know [J].

Antoniou, C. ;

Kosmadaki, M. G. ;

Stratigos, A. J. ;

Katsambas, A. D. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (09) :1110-1119

[5]

Arenas R, 2009, ATLAS DERMATOLOGIA D

[6]

Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185

[7] High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].

Atkins, MB ;

Lotze, MT ;

Dutcher, JP ;

Fisher, RI ;

Weiss, G ;

Margolin, K ;

Abrams, J ;

Sznol, M ;

Parkinson, D ;

Hawkins, M ;

Paradise, C ;

Kunkel, L ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116

[8] Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].

Balch, CM ;

Buzaid, AC ;

Soong, SJ ;

Atkins, MB ;

Cascinelli, N ;

Coit, DG ;

Fleming, ID ;

Gershenwald, JE ;

Houghton, A ;

Kirkwood, JM ;

McMasters, KM ;

Mihm, MF ;

Morton, DL ;

Reintgen, DS ;

Ross, MI ;

Sober, A ;

Thompson, JA ;

Thompson, JF .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648

[9] Incidence of new and changed Nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma [J].

Banky, JP ;

Kelly, JW ;

English, DR ;

Yeatman, JM ;

Dowling, JP .

ARCHIVES OF DERMATOLOGY, 2005, 141 (08) :998-1006

[10] COST-EFFECTIVENESS OF SURVEILLANCE OF STAGE-I MELANOMA - A RETROSPECTIVE APPRAISAL BASED ON A 10-YEAR EXPERIENCE IN A DERMATOLOGY DEPARTMENT IN FRANCE [J].

BASSERES, N ;

GROB, JJ ;

RICHARD, MA ;

THIRION, X ;

ZAROUR, H ;

NOE, C ;

COLLETVILETTE, AM ;

LOTA, I ;

BONERANDI, JJ .

DERMATOLOGY, 1995, 191 (03) :199-203

← 1 2 3 4 5 6 →